B cell activation through CD40 and IL4R ligation modulates the response of chronic lymphocytic leukaemia cells to BAFF and APRIL

British Journal of Haematology

Volumn 164, Issue 4, 2014, Pages 570-578

  Ferrer, Gerardo ^a   Bosch, Rosa ^b   Hodgson, Kate ^c   Tejero, Rut ^a   Roué, Gael ^a   Colomer, Dolors ^a   Montserrat, Emili ^a   Moreno, Carol ^b  

^a UNIVERSITY OF BARCELONA   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^c LEICESTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

A proliferation inducing ligand; B cell maturation antigen; B cell activating factor; Chronic lymphocytic leukaemia; Receptors modulation

Indexed keywords

APRIL PROTEIN; B CELL ACTIVATING FACTOR RECEPTOR; B CELL MATURATION ANTIGEN; B LYMPHOCYTE RECEPTOR; CD40 ANTIGEN; INTERLEUKIN 4 RECEPTOR;

ADULT; ANTIGEN EXPRESSION; ARTICLE; B LYMPHOCYTE ACTIVATION; CANCER PROGNOSIS; CANCER SURVIVAL; CELL VIABILITY; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; GENETIC RISK; HUMAN; HUMAN CELL; IGHV GENE; LEUKEMIA CELL; MALE; MIDDLE AGED; ONCOGENE; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; PROTEIN EXPRESSION; RISK ASSESSMENT; RISK FACTOR; SENSITIVITY ANALYSIS; SIGNAL TRANSDUCTION;

A PROLIFERATION-INDUCING LIGAND; B-CELL MATURATION ANTIGEN; B-CELL-ACTIVATING FACTOR; CHRONIC LYMPHOCYTIC LEUKAEMIA; RECEPTORS MODULATION;

ANTIGENS, CD40; B-CELL ACTIVATING FACTOR; B-CELL ACTIVATION FACTOR RECEPTOR; B-LYMPHOCYTES; FEMALE; HUMANS; INTERLEUKIN-4 RECEPTOR ALPHA SUBUNIT; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; RECEPTORS, ANTIGEN, B-CELL; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 13; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84892950666     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/bjh.12645     Document Type: Article

References (48)

1. Acosta-Rodriguez, E.V., Craxton, A., Hendricks, D.W., Merino, M.C., Montes, C.L., Clark, E.A. & Gruppi, A. (2007) BAFF and LPS cooperate to induce B cells to become susceptible to CD95/Fas-mediated cell death. European Journal of Immunology, 37, 990-1000.
2. Bojarska-Junak, A., Hus, I., Chocholska, S., Wasik-Szczepanek, E., Sieklucka, M., Dmoszynska, A. & Rolinski, J. (2009) BAFF and APRIL expression in B-cell chronic lymphocytic leukemia: correlation with biological and clinical features. Leukemia Research, 33, 1319-1327.
3. Burger, J.A. (2011) Nurture versus nature: the microenvironment in chronic lymphocytic leukemia. Hematology American Society of Hematology Education Program, 2011, 96-103.
4. Byrd, J.C., Kipps, T.J., Flinn, I.W., Cooper, M., Odenike, O., Bendiske, J., Rediske, J., Bilic, S., Dey, J., Baeck, J. & O'Brien, S. (2012) Phase I study of the anti-CD40 humanized monoclonal antibody lucatumumab (HCD122) in relapsed chronic lymphocytic leukemia. Leukaemia & Lymphoma, 53, 2136-2142.
5. Caligaris-Cappio, F. & Ghia, P. (2008) Novel insights in chronic lymphocytic leukemia: are we getting closer to understanding the pathogenesis of the disease? Journal of Clinical Oncology, 26, 4497-4503.
6. Castigli, E., Wilson, S.A., Garibyan, L., Rachid, R., Bonilla, F., Schneider, L. & Geha, R.S. (2005) TACI is mutant in common variable immunodeficiency and IgA deficiency. Nature Genetics, 37, 829-834.
7. Chiorazzi, N., Rai, K.R. & Ferrarini, M. (2005) Chronic lymphocytic leukemia. New England Journal of Medicine, 352, 804-815.
8. Collins, R.J., Verschuer, L.A., Harmon, B.V., Prentice, R.L., Pope, J.H. & Kerr, J.F. (1989) Spontaneous programmed death (apoptosis) of B-chronic lymphocytic leukaemia cells following their culture in vitro. British Journal of Haematology, 71, 343-350.
9. Cols, M., Barra, C.M., He, B., Puga, I., Xu, W., Chiu, A., Tam, W., Knowles, D.M., Dillon, S.R., Leonard, J.P., Furman, R.R., Chen, K. & Cerutti, A. (2012) Stromal endothelial cells establish a bidirectional crosstalk with chronic lymphocytic leukemia cells through the TNF-related factors BAFF, APRIL, and CD40L. Journal of Immunology, 188, 6071-6083.
10. Crowley, J.E., Stadanlick, J.E., Cambier, J.C. & Cancro, M.P. (2009) FcgammaRIIB signals inhibit BLyS signaling and BCR-mediated BLyS receptor up-regulation. Blood, 113, 1464-1473.
11. Darce, J.R., Arendt, B.K., Wu, X. & Jelinek, D.F. (2007) Regulated expression of BAFF-binding receptors during human B cell differentiation. Journal of Immunology, 179, 7276-7286.
12. Efremov, D.G., Gobessi, S. & Longo, P.G. (2007) Signaling pathways activated by antigen-receptor engagement in chronic lymphocytic leukemia B-cells. Autoimmunity Reviews, 7, 102-108.
13. Endo, T., Nishio, M., Enzler, T., Cottam, H.B., Fukuda, T., James, D.F., Karin, M. & Kipps, T.J. (2007) BAFF and APRIL support chronic lymphocytic leukemia B-cell survival through activation of the canonical NF-kappaB pathway. Blood, 109, 703-710.
14. Fagarasan, S. & Honjo, T. (2000) T-Independent immune response: new aspects of B cell biology. Science, 290, 89-92.
15. Ferrer, G., Hodgson, K., Montserrat, E. & Moreno, C. (2009) B cell activator factor and a proliferation-inducing ligand at the cross-road of chronic lymphocytic leukemia and autoimmunity. Leukaemia & Lymphoma, 50, 1075-1082.
16. Ferrer, G., Hodgson, K., Pereira, A., Juan, M., Elena, M., Colomer, D., Roue, G., Aymerich, M., Baumann, T., Montserrat, E. & Moreno, C. (2011) Combined analysis of levels of serum B-cell activating factor and a proliferation-inducing ligand as predictor of disease progression in patients with chronic lymphocytic leukemia. Leukaemia & Lymphoma, 52, 2064-2068.
17. Ghamlouch, H., Ouled-Haddou, H., Damaj, G., Royer, B., Gubler, B. & Marolleau, J.P. (2013) A combination of cytokines rescues highly purified leukemic CLL B-cells from spontaneous apoptosis in vitro. PLoS One, 8, e60370.
18. Groom, J.R., Fletcher, C.A., Walters, S.N., Grey, S.T., Watt, S.V., Sweet, M.J., Smyth, M.J., Mackay, C.R. & Mackay, F. (2007) BAFF and MyD88 signals promote a lupuslike disease independent of T cells. Journal of Experimental Medicine, 204, 1959-1971.
19. Guadagnoli, M., Kimberley, F.C., Phan, U., Cameron, K., Vink, P.M., Rodermond, H., Eldering, E., Kater, A.P., van Eenennaam, H. & Medema, J.P. (2011) Development and characterization of APRIL antagonistic monoclonal antibodies for treatment of B-cell lymphomas. Blood, 117, 6856-6865.
20. Haiat, S., Billard, C., Quiney, C., Ajchenbaum-Cymbalista, F. & Kolb, J.P. (2006) Role of BAFF and APRIL in human B-cell chronic lymphocytic leukaemia. Immunology, 118, 281-292.
21. He, B., Chadburn, A., Jou, E., Schattner, E.J., Knowles, D.M. & Cerutti, A. (2004) Lymphoma B cells evade apoptosis through the TNF family members BAFF/BLyS and APRIL. Journal of Immunology, 172, 3268-3279.
22. Hothorn, T. & Lausen, B. (2003) On the exact distribution of maximally selected rank statistics. Computational Statistics & Data Analysis, 43, 121-137.
23. Kern, C., Cornuel, J.F., Billard, C., Tang, R.P., Rouillard, D., Stenou, V., Defrance, T., Ajchenbaum-Cymbalista, F., Simonin, P.Y., Feldblum, S. & Kolb, J.P. (2004) Involvement of BAFF and APRIL in the resistance to apoptosis of B-CLL through an autocrine pathway. Blood, 103, 679-688.
24. Lanham, S., Hamblin, T., Oscier, D., Ibbotson, R., Stevenson, F. & Packham, G. (2003) Differential signaling via surface IgM is associated with VH gene mutational status and CD38 expression in chronic lymphocytic leukemia. Blood, 10, 11087-11093.
25. Longo, P.G., Laurenti, L., Gobessi, S., Petlickovski, A., Pelosi, M., Chiusolo, P., Sica, S., Leone, G. & Efremov, D.G. (2007) The Akt signaling pathway determines the different proliferative capacity of chronic lymphocytic leukemia B-cells from patients with progressive and stable disease. Leukemia, 21, 110-120.
26. Mittag, A. & Tarnok, A. (2009) Basics of standardization and calibration in cytometry - a review. Journal of Biophotonics, 2, 470-481.
27. Molica, S., Digiesi, G., Battaglia, C., Cutrona, G., Antenucci, A., Molica, M., Giannarelli, D., Sperduti, I., Gentile, M., Morabito, F. & Ferrarini, M. (2010) Baff serum level predicts time to first treatment in early chronic lymphocytic leukemia. European Journal of Haematology, 85, 314-320.
28. Morabito, F., Cutrona, G., Gentile, M., Fabbi, M., Matis, S., Colombo, M., Reverberi, D., Megna, M., Spriano, M., Callea, V., Vigna, E., Rossi, E., Lucia, E., Festini, G., Zupo, S., Molica, S., Neri, A. & Ferrarini, M. (2010) Prognostic relevance of in vitro response to cell stimulation via surface IgD in binet stage a CLL. British Journal of Haematology, 149, 160-163.
29. Müller-Hermelink, H.K., Montserrat, E., Catovsky, D., Campo, E., Harris, N.L. & Stein, H. (2008) Chronic lymphocytic leukaemia/small lymphocytic lymphoma. In: WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues (ed. by H.S. Swerdlow, E. Campo, N.L. Harris, E.S. Jaffe, S.A. Pileri, H. Stein, J. Thiele & J.W. Vardiman), pp. 180-182. International Agency for Research on Cancer, Lyon.
30. Muzio, M., Apollonio, B., Scielzo, C., Frenquelli, M., Vandoni, I., Boussiotis, V., Caligaris-Cappio, F. & Ghia, P. (2008) Constitutive activation of distinct BCR-signaling pathways in a subset of CLL patients: a molecular signature of anergy. Blood, 112, 188-195.
31. Nimmanapalli, R., Lyu, M.A., Du, M., Keating, M.J., Rosenblum, M.G. & Gandhi, V. (2007) The growth factor fusion construct containing B-lymphocyte stimulator (BLyS) and the toxin rGel induces apoptosis specifically in BAFF-R-positive CLL cells. Blood, 109, 2557-2564.
32. Nishio, M., Endo, T., Tsukada, N., Ohata, J., Kitada, S., Reed, J.C., Zvaifler, N.J. & Kipps, T.J. (2005) Nurselike cells express BAFF and APRIL, which can promote survival of chronic lymphocytic leukemia cells via a paracrine pathway distinct from that of SDF-1alpha. Blood, 106, 1012-1020.
33. Novak, A.J., Grote, D.M., Stenson, M., Ziesmer, S.C., Witzig, T.E., Habermann, T.M., Harder, B., Ristow, K.M., Bram, R.J., Jelinek, D.F., Gross, J.A. & Ansell, S.M. (2004) Expression of BLyS and its receptors in B-cell non-Hodgkin lymphoma: correlation with disease activity and patient outcome. Blood, 104, 2247-2253.
34. O'Connor, B.P., Raman, V.S., Erickson, L.D., Cook, W.J., Weaver, L.K., Ahonen, C., Lin, L.L., Mantchev, G.T., Bram, R.J. & Noelle, R.J. (2004) BCMA is essential for the survival of long-lived bone marrow plasma cells. Journal of Experimental Medicine, 199, 91-97.
35. Panayiotidis, P., Ganeshaguru, K., Jabbar, S.A. & Hoffbrand, A.V. (1993) Interleukin-4 inhibits apoptotic cell death and loss of the bcl-2 protein in B-chronic lymphocytic leukaemia cells in vitro. British Journal of Haematology, 85, 439-445.
36. Plander, M., Seegers, S., Ugocsai, P., Diermeier-Daucher, S., Ivanyi, J., Schmitz, G., Hofstadter, F., Schwarz, S., Orso, E., Knuchel, R. & Brockhoff, G. (2009) Different proliferative and survival capacity of CLL-cells in a newly established in vitro model for pseudofollicles. Leukemia, 23, 2118-2128.
37. Planelles, L., Castillo-Gutierrez, S., Medema, J.P., Morales-Luque, A., Merle-Beral, H. & Hahne, M. (2007) APRIL but not BLyS serum levels are increased in chronic lymphocytic leukemia: prognostic relevance of APRIL for survival. Haematologica, 92, 1284-1285.
38. Sasaki, Y., Casola, S., Kutok, J.L., Rajewsky, K. & Schmidt-Supprian, M. (2004) TNF family member B cell-activating factor (BAFF) receptor-dependent and -independent roles for BAFF in B cell physiology. Journal of Immunology, 173, 2245-2252.
39. Shulga-Morskaya, S., Dobles, M., Walsh, M.E., Ng, L.G., MacKay, F., Rao, S.P., Kalled, S.L. & Scott, M.L. (2004) B cell-activating factor belonging to the TNF family acts through separate receptors to support B cell survival and T cell-independent antibody formation. Journal of Immunology, 173, 2331-2341.
40. Smith, S.H. & Cancro, M.P. (2003) Cutting edge: B cell receptor signals regulate BLyS receptor levels in mature B cells and their immediate progenitors. Journal of Immunology, 170, 5820-5823.
41. Tavolaro, S., Peragine, N., Chiaretti, S., Ricciardi, M.R., Raponi, S., Messina, M., Santangelo, S., Marinelli, M., Di Maio, V., Mauro, F.R., Del Giudice, I., Foà, R. & Guarini, A. (2013) IgD cross-linking induces gene expression profiling changes and enhances apoptosis in chronic lymphocytic leukemia cells. Leukemia Research, 37, 455-462.
42. Tecchio, C., Nichele, I., Mosna, F., Zampieri, F., Leso, A., Al-Khaffaf, A., Veneri, D., Andreini, A., Pizzolo, G. & Ambrosetti, A. (2011) A proliferation-inducing ligand (APRIL) serum levels predict time to first treatment in patients affected by B-cell chronic lymphocytic leukemia. European Journal of Haematology, 87, 228-234.
43. Thompson, J.S., Bixler, S.A., Qian, F., Vora, K., Scott, M.L., Cachero, T.G., Hession, C., Schneider, P., Sizing, I.D., Mullen, C., Strauch, K., Zafari, M., Benjamin, C.D., Tschopp, J., Browning, J.L. & Ambrose, C. (2001) BAFF-R, a newly identified TNF receptor that specifically interacts with BAFF. Science, 293, 2108-2111.
44. Treml, L.S., Carlesso, G., Hoek, K.L., Stadanlick, J.E., Kambayashi, T., Bram, R.J., Cancro, M.P. & Khan, W.N. (2007) TLR stimulation modifies BLyS receptor expression in follicular and marginal zone B cells. Journal of Immunology, 178, 7531-7539.
45. Walmsley, M.J., Ooi, S.K., Reynolds, L.F., Smith, S.H., Ruf, S., Mathiot, A., Vanes, L., Williams, D.A., Cancro, M.P. & Tybulewicz, V.L. (2003) Critical roles for Rac1 and Rac2 GTPases in B cell development and signaling. Science, 302, 459-462.
46. Xia, X.Z., Treanor, J., Senaldi, G., Khare, S.D., Boone, T., Kelley, M., Theill, L.E., Colombero, A., Solovyev, I., Lee, F., McCabe, S., Elliott, R., Miner, K., Hawkins, N., Guo, J., Stolina, M., Yu, G., Wang, J., Delaney, J., Meng, S.Y., Boyle, W.J. & Hsu, H.L. (2000) TACI is a TRAF-interacting receptor for TALL-1, a tumor necrosis factor family member involved in B cell regulation. Journal of Experimental Medicine, 192, 137-143.
47. Xu, S.L. & Lam, K.P. (2001) B-cell maturation protein, which binds the tumor necrosis factor family members BAFF and APRIL, is dispensable for humoral immune responses. Molecular and Cellular Biology, 21, 4067-4074.
48. Yan, M., Wang, H., Chan, B., Roose-Girma, M., Erickson, S., Baker, T., Tumas, D., Grewal, I.S. & Dixit, V.M. (2001) Activation and accumulation of B cells in TACI-deficient mice. Nature Immunology, 2, 638-643.